Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
ImClone Metastatic Breast Cancer Candidate Moves Into Phase III In Third Quarter
22 Apr 2008
•
By
Brooke McManus
Firm sets progression-free survival as primary endpoint for 1,100-patient trial.
More from Archive
More from Pink Sheet